Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
3
×
life sciences
national blog main
san francisco blog main
san francisco top stories
biotech
boston top stories
national top stories
new york blog main
new york top stories
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
amgen
andrew oxtoby
babies
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
cancer diagnostics
ceo
cholesterol
clinical hold
clinical study
clinical trials
combination
commissioner
congress
crispr
crispr-cas9
data
delisting
democrats
departure
detroit blog main
detroit top stories
drug pricing
editas medicine
What
medicine
3
×
week
3
×
announced
big
ceo
aces
area
based
bay
bio
biopsy
blood
bosley's
bosley’s
bridge
bucks
buildout
cancer
cas
cholesterol
close
company
crime
crispr
departure
developing
drug
editas
exit
firm
flexible
genomic
guiding
inclisiran
katrine
key
liquid
lowering
lucence
meant
Language
unset
Current search:
week
×
" boston blog main "
×
medicine
×
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More